Predicted to enable chromatin-protein adaptor activity; miRNA inhibitor activity via base-pairing; and ribonucleoprotein complex binding activity. Predicted to be involved in lncRNA-mediated post-transcriptional gene silencing; positive regulation of miRNA catabolic process; and regulatory ncRNA-mediated heterochromatin formation. Predicted to act upstream of or within inactivation of paternal X chromosome by genomic imprinting; random inactivation of X chromosome; and spongiotrophoblast differentiation. Predicted to be located in X chromosome and nuclear body. Predicted to be part of ribonucleoprotein complex.
RGD Description
Predicted to enable chromatin-protein adaptor activity; miRNA inhibitor activity via base-pairing; and ribonucleoprotein complex binding activity. Predicted to be involved in lncRNA-mediated post-transcriptional gene silencing; positive regulation of miRNA catabolic process; and regulatory ncRNA-mediated heterochromatin formation. Predicted to act upstream of or within inactivation of paternal X chromosome by genomic imprinting; random inactivation of X chromosome; and spongiotrophoblast differentiation. Predicted to be located in X chromosome and nuclear body. Predicted to be part of ribonucleoprotein complex; INTERACTS WITH 17beta-estradiol; bisphenol A; (S)-nicotine (ortholog).